CCCC vs MTB · rev $35.6M vs P/E 12, $30.99B cap
C4 Therapeutics Inc (CCCC) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
MTB does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the CCCC and MTB stock pages for the full models.
Not investment advice.